MMEA
GH icon

Main Management ETF Advisors’s Guardant Health GH Stock Holding History

Main Management ETF Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,622
Closed -$2.72M – 142
2025
Q4 		$2.72M Buy
26,622
+272
+1% +$24.3K 0.1% 33
2025
Q3 		$1.65M Buy
26,350
+5,093
+24% +$277K 0.06% 68
2025
Q2 		$1.11M Buy
21,257
+348
+2% +$15.5K 0.05% 75
2025
Q1 		$891K Buy
+20,909
New +$902K 0.04% 79

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Main Management ETF Advisors's GH Position: Q1 2026 in Review

Main Management ETF Advisors sold out of Guardant Health (GH) in Q1 2026, closing a stake of 26,622 shares — an estimated $2.72M sold.

Main Management ETF Advisors first reported a position in GH in Q1 2025 and held it in 4 quarters. The position peaked at $2.72M in Q4 2025. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Main Management ETF Advisors reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Main Management ETF Advisors sold 26,622 Guardant Health shares in Q1 2026, an estimated $2.72M.
  • Main Management ETF Advisors first reported a position in Guardant Health in Q1 2025 and held it in 4 quarters.
  • Main Management ETF Advisors's Guardant Health position peaked at $2.72M in Q4 2025.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Main Management ETF Advisors's 13F filing for Q1 2026, filed 15 May 2026.